Korean J Pediatr.
2015 Aug;58(8):275-282. 10.3345/kjp.2015.58.8.275.
Nephrotic syndrome: what's new, what's hot?
- Affiliations
-
- 1Department of Pediatrics, Research Coordination Center for Rare Diseases, Seoul National University Children's Hospital, Seoul, Korea. cheonghi@snu.ac.kr
- KMID: 2284601
- DOI: http://doi.org/10.3345/kjp.2015.58.8.275
Abstract
- While the incidence of nephrotic syndrome (NS) is decreasing in Korea, the morbidity of difficult-to-treat NS is significant. Efforts to minimize treatment toxicity showed that prolonged treatment after an initial treatment for 2-3 months with glucocorticosteroids was not effective in reducing frequent relapses. For steroid-dependent NS, rituximab, a monoclonal antibody against the CD20 antigen on B cells, was proven to be as effective, and short-term daily low-dose steroids during upper respiratory infections reduced relapses. Steroid resistance or congenital NS are indications for genetic study and renal biopsy, since the list of genes involved in NS is lengthening.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Can We Predict How Often Nephrotic Syndrome will Relapse into the Patients?
- A Case of Levamisole Treatment for Kimura's Disease-Associated Nephrotic Syndrome
- A Study of Serum Cytokines in Nephrotic Syndrome
- Re-evaluation of the indication for renal biopsy in childhood nephrotic syndrome
- Acute Leukoencephalopathy During Cyclosporin A Therapy in a Pediatric Patient with Nephrotic Syndrome
